The work of the Tang Prize winners in biopharmaceutical science has revolutionized the genome editing platform, making it programmable like never before, and could help tackle complicated human diseases, both scholars and Tang Prize Selection Committee members said on Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end down amid Middle East tensions
06/16/2025 04:25 PM - Sports
Gadiaga joins DEA on five-year contract
06/16/2025 04:20 PM - Business
U.S. dollar closes sharply lower on Taipei forex market
06/16/2025 04:16 PM - Society
6 indicted over NT$5 billion investment scam targeting garment magnate
06/16/2025 04:16 PM - Society
Cancer top cause of death in Taiwan in 2024, suicides on the rise
06/16/2025 03:50 PM